Osaic Holdings
PBYI icon

Osaic Holdings’s Puma Biotechnology PBYI Stock Holding History

Osaic Holdings’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$98.7K Buy
12,169
+500
+4% +$3.66K ﹤0.01% 4958
2026
Q1 		$74.6K Sell
11,669
-500
-4% -$3.22K ﹤0.01% 4897
2025
Q4 		$72.4K Sell
12,169
-6,094
-33% -$32.4K ﹤0.01% 4972
2025
Q3 		$96K Buy
18,263
+319
+2% +$1.35K ﹤0.01% 4821
2025
Q2 		$61.5K Buy
17,944
+450
+3% +$1.44K ﹤0.01% 4898
2025
Q1 		$51.8K Buy
17,494
+16,851
+2,621% +$52.7K ﹤0.01% 4691
2024
Q4 		$1.96K Sell
643
-334
-34% -$972 ﹤0.01% 6619
2024
Q3 		$2.49K Hold
977
– – ﹤0.01% 6520
2024
Q2 		$3.19K Buy
977
+327
+50% +$1.44K ﹤0.01% 6399
2024
Q1 		$3.44K Buy
650
+300
+86% +$1.62K ﹤0.01% 6248
2023
Q4 		$1.52K Buy
350
+200
+133% +$663 ﹤0.01% 6628
2023
Q3 		$395 Sell
150
-16,064
-99% -$54.7K ﹤0.01% 7035
2023
Q2 		$51.9K Sell
16,214
-727
-4% -$2.27K ﹤0.01% 4917
2023
Q1 		$49.7K Sell
16,941
-489
-3% -$1.84K ﹤0.01% 4958
2022
Q4 		$74K Sell
17,430
-52
-0.3% -$179 ﹤0.01% 4664
2022
Q3 		$42K Buy
17,482
+2,502
+17% +$7.31K ﹤0.01% 5035
2022
Q2 		$42K Sell
14,980
-280
-2% -$696 ﹤0.01% 5089
2022
Q1 		$33K Sell
15,260
-311
-2% -$804 ﹤0.01% 5388
2021
Q4 		$49K Sell
15,571
-13,648
-47% -$59.2K ﹤0.01% 5167
2021
Q3 		$196K Buy
29,219
+14,642
+100% +$110K ﹤0.01% 3921
2021
Q2 		$134K Buy
14,577
+1,517
+12% +$15.4K ﹤0.01% 4227
2021
Q1 		$127K Buy
13,060
+920
+8% +$10.3K ﹤0.01% 4161
2020
Q4 		$124K Sell
12,140
-2,370
-16% -$24K ﹤0.01% 3898
2020
Q3 		$147K Buy
14,510
+4,155
+40% +$42.3K ﹤0.01% 3516
2020
Q2 		$108K Buy
10,355
+815
+9% +$8.44K ﹤0.01% 3630
2020
Q1 		$80K Buy
+9,540
New +$92.7K ﹤0.01% 3643

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings's PBYI Position: Q2 2026 in Review

Osaic Holdings increased its Puma Biotechnology (PBYI) stake by 4.3% in Q2 2026, buying an estimated $3.66K and bringing the position to 12,169 shares worth $98.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4958.

Osaic Holdings first reported a position in PBYI in Q1 2020 and has held it in 26 quarters since. The position peaked at $196K in Q3 2021. 160 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

  • Osaic Holdings held 12,169 shares of Puma Biotechnology worth $98.7K as of Q2 2026.
  • Osaic Holdings bought 500 Puma Biotechnology shares in Q2 2026, an estimated $3.66K.
  • Puma Biotechnology made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4958 holding.
  • Osaic Holdings first reported a position in Puma Biotechnology in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Puma Biotechnology position peaked at $196K in Q3 2021.
  • 160 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.